Disease Ibd Product Applications

2 applications found

Medical diagnostics solutions for inflammatory bowel disease sector

Inflammatory bowel disease (IBD), largely comprising the two conditions, Crohn’s Disease and Ulcerative Colitis, is now emerging as a global health problem. It now affects about 6 million people in Europe and US, comprising up to 620,000 in the UK (IBD Standards UK, 2013 Update). The symptoms of diarrhoea, abdominal pain and bloody stool substantially affect the quality of life of sufferers, and complications can be life threatening. ...

ByDiagNodus Ltd. based in Cambridge, UNITED KINGDOM

Microbiome Therapeutics for Clinical Trials

Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...

ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you